Rhesus monkeys are useful models in which to examine the hormonal regulation of endometrial matrix metalloproteinases (MMP) and to evaluate the role of MMP in uterine bleeding. Artificial 28 day menstrual cycles can be induced in ovariectomized monkeys by inserting an oestradiol implant for 2 weeks, then inserting a progesterone implant for 2 weeks, and then, with the oestradiol implant remaining in place, removing and reinserting the progesterone implant at 2 week intervals. To examine MMP during menses, we established such cycles and removed uteri by hysterectomy at closely spaced intervals before, during and after menses, as well as at Liter time points. Some samples were also obtained during menses induced by the withdrawal of both progesterone and oestradiol. We examined mRNA of the following MMP by Northern blotting: matrilysin, stromelysin-1, stromelysin-2, stromelysin-3 and the tissue inhibitor of MMP TTMP-1. The expression of these MMP mRNA increased substantially by 2-3 days after progesterone withdrawal, whether or not oestradiol was maintained. The expression of some of the MMP (stromelysins-1 and -2) returned very rapidly to baseline levels by 5 days after progesterone withdrawal, while the expression of others (matrilysin, stromelysin-3 and TIMP-1) declined more slowly, reaching a baseline level by 10 days after progesterone withdrawal, with little or no further decline after progesterone concentrations rose during the induced luteal phase. Immunocytochemical studies showed that matrilysin was expressed primarily in the glands of the upper functionalis. In other work with the rhesus monkey model, we used a s.c endometrial autograft technique in which pieces of endometrium were autotransplanted to the abdominal skin. During menses in the grafts, matrilysin was expressed in the glands of the grafts similar to the glands in the eutopic endometrium. Endometrial autografts can serve as a useful model for the study of MMP hi uterine bleeding.
Introduction

The primate background
Menstruating non-human primates have been used over the past 50-60 years to gain insight into the hormonal regulation of the endometrial cycle and the mechanisms underlying menstruation. In the 1930s and 1940s, pioneers, including Hisaw, Markee, Hartmann and Bartelmez (Bartelmez, 1933 (Bartelmez, , 1951 (Bartelmez, , 1957 Hartman, 1944; Markee, 1940 Markee, , 1948 Markee, , 1950 Hisaw and Hisaw, 1961) , documented the value of the rhesus monkey as an animal model. Among a number of important points these workers established were the following. First, if spayed or immature animals were treated with oestrogen for a few weeks, the endometrium would increase dramatically in thickness to a stable size but would not thicken further, even if higher oestrogen doses or longer treatments were used. Such an oestrogen-primed endometrium would bleed if the oestrogen dose fell below a critical threshold value, or if oestrogen treatment stopped, provided the treatment period had been at least a few weeks long. These data indicated that the vasculature of an oestrogenized endometrium was dependent on oestrogen for functional integrity.
However, if progestin treatment was begun immediately after the oestradiol treatment, bleeding was inhibited and endometrial growth renewed. During progestin treatment, breakthrough bleeding would occur if the progestin level fell below a critical threshold value, regardless of the oestrogen level. After a minimal period of progestin treatment (~3 days) of an oestrogen-primed endometrium, progestin withdrawal was always followed by uterine bleeding, and this progesterone-withdrawal bleeding could not be prevented by oestrogen (Hisaw and Hisaw, 1961) . These findings indicated that progestin treatment transformed the endometrium and its vasculature into a primarily progesterone-dependent rather than an oestrogendependent state. The cellular mechanisms responsible for this transformation and for the change in vascular sensitivity remain to be identified.
A deeper understanding of the specific vascular changes involved in menstrual bleeding came from Markee's (1940 Markee's ( , 1948 Markee's ( , 1950 pioneering work. He autotransplanted endometrial fragments into the anterior chamber of the eye in rhesus monkeys and studied the periodic menstrual bleeding that occurred in such grafts. Markee noted that the first and most reliable sign of impending menstruation was a slowing of blood flow in the upper endometrial regions, accompanied by a reduction in endometrial thickness due to fluid reabsorption. This shrinkage, or premenstrual regression, began 2 days before bleeding and continued throughout the bleeding episode. The second key event was compression of the spiral arteries. These coiled vessels buckled 'as a bedspring might if it were unduly compressed' (Markee, 1950) to accommodate the shrinkage of the endometrium. As a consequence, blood flow through these vessels was greatly reduced. The third event was an extensive vasoconstriction of the spiral arteries, especially in the basal regions of the endometrium, which further reduced blood flow to the upper zones. The vascular stasis induced by such compression and vasoconstriction led to an anoxic insult that weakened the capillary bed. At intervals, the constricted spiral arteries relaxed, and the renewed blood flow through the weakened vessels in the subluminal vascular plexus ruptured their walls and initiated menses.
The anoxic insult was presumed to induce death and sloughing of the upper zones. Fragments of tissue in the upper endometrial regions became undermined by fissures, and the cleaving off, or 'crumbling away', of these tissue fragments often revealed the tips of spiral arteries spurting blood. Eventually the bleeding ceased after the spiral arteries sealed off spontaneously, and new networks of capillaries and veins became established in the middle third of the functional zone. Normal circulation slowly developed in this region as tissue regression ended and oestrogen-dependent regeneration ensued. Remarkably, the grafted pieces of endometrium regenerated as miniature endometria which bled and sloughed from their upper zones and regenerated from their lower ones. Markee noted that during menses, the straight arteries in the basal zones of the grafts remained patent and supplied the lower regions of the grafts with normal circulatory flow.
These phenomena, so beautifully described in 1940, have not yet been fully explained at the cellular or molecular level. Why are the spiral and basal arteries, which derive from the same arterial roots, so functionally different? What tissue factors are generated by anoxia? What specifically leads to the weakening and rupture of vessel walls? What underlies the fissuring, disruption and dissolution of the tissues of the upper functional zones? What brings about the final cessation of bleeding in the normal menstrual process? What mechanisms underlie breakthrough bleeding?
The metalloproteinases Recent information on the role of matrix metalloproteinases (MMP) in tissue remodelling has led various laboratories, including our own, to focus on the potential role of these enzymes during menstruation and other episodes of uterine bleeding.
MMP consist of a family of zinc metalloenzymes divided into three major types: type I collagenases, gelatinases and stromelysins. All are secreted proteins found in increased amounts in the extracellular matrix during injury, inflammation and the metastatic spread of cancer cells (McDonnell et al.. 1994) . Type I collagenases (interstitial collagenase, neutrophil collagenase and collagenase-3) degrade interstitial collagens, and gelatinases (A and B) degrade basement membrane collagens and gelatin. The stromelysins are of four kinds: stromelysin-1, stromelysin-2, stromelysin-3 and matrilysin. Stromelysins-1 and -2 can break down fibronectin, laminin and proteoglycans. Stromelysin-3 has been implicated in the invasiveness of breast cancer, but its ability to degrade matrix components may be somewhat limited (Murphy et aL, 1993) . Matrilysin degrades glycoproteins and proteoglycans effectively and is produced primarily in epithelial cells, while all the other stromelysins are specifically produced by stromal cells (see Rodgers et aL, 1994, for example) . The recent isolation of several new members of the MMP family suggest that this useful, but perhaps simplistic, classification of MMP may need to be revised.
MMP can be regulated at the transcriptional level, both positively and negatively, by various growth factors, cytokines, oncogenes and tumour promoters. For example, epidermal growth factor/ transforming growth factor (TGF)-a can up-regulate and TGF-(3 can down-regulate certain MMP (Matrisian and, Hogan, 1990) . TGF-p produced by endometrial stromal cells has been reported to inhibit matrilysin production by epithelial cells (Bruner etaL, 1995) . Post-translational control also occurs, as the MMP are secreted as proenzymes that are latent until activated by proteolytic cleavage. There are also several endogenous inhibitors of the MMP, such as tissue inhibitor of MMP (TOIP-1; McDonnell et aL, 1994) , that can block MMP function within the extracellular matrix.
The primate endometrium is one of a few normal (non-cancerous) tissues in which dramatic, regulated changes in metalloproteinase synthesis have been observed (McDonnell et aL, 1994 ). Marbaix's laboratory was the first to report (Marbaix et aL, 1992) that interstitial collagenase was expressed in organ cultures of human endometrium and that progesterone could inhibit this expression (Marbaix et aL, 1992 (Marbaix et aL, , 1995 . Martelli et aL (1993) reported that purified preparations of stromal and epithelial cells from human endometrium cultured under different conditions expressed various MMP. In other studies of the human endometrium, in-situ hybridization, Northern analysis and immunocytochemistry showed that matrilysin mRNA was expressed in the glandular epithelium and stromelysins-1, -2 and -3 were detected exclusively in stromal cells. Matrilysin, stromelysin-1 and stromelysin-3 were only expressed in the follicular phase and during menstruation, and stromelysin-2 was only expressed during menstruation. TTMP-1 was present throughout the cycle, with some increase during menstruation (Rodgers et al., 1993 ). Salamonsen's laboratory also described the limited expression of various MMP in human endometrium during the menstrual cycle. For example, MMP-1 (interstitial collagenase) and MMP-3 (stromelysin-1) mRNA expression was restricted to the premenstrual period and during menses. By day 5 in the follicular phase, the expression of these two mRNAs had become undetectable and did not increase until the end of the luteal phase (Hampton and Salamonsen, 1994; Salamonsen, 1994) . These latter data suggest that in vivo the expression of these MMP mRNA declines well before the postovulatory rise in serum progesterone.
Clearly, MMP could play important roles in the breakdown of tissue architecture in the endometrium during menses, and may participate in tissue remodelling during endometrial regeneration and repair. However, the specific role of any single MMP at any particular phase of the menses-repair process remains to be clarified. For example, it has not yet been established unequivocally that MMP play a role in the rupture of any blood vessels, although such a possibility is extremely likely. Moreover, our preliminary evidence (Rudolph et aL, 1994) suggested that there were differences in the actions of progesterone in vivo versus in vitro.
Consequently, we are evaluating the regulation and localization of MMP during the mensesrepair-regeneration sequence in the rhesus monkey (Rudolph et aL, 1994) . In addition, Markee's work inspired us to develop a technique for autografting rhesus monkey endometrium into s.c. sites, where they would be more accessible for frequent sequential biopsies. Here we also describe some aspects of this technique and review our preliminary findings on matrilysin in these grafts.
Materials and methods
Animal procedures
A total of 19 ovariectomized rhesus monkeys (Macaca mulatto) were used in this study. These animals were used because they are easily induced to menstruate under hormonal control and because our laboratory has reported extensively on the hormonal regulation of reproductive processes in the rhesus monkey (Brenner et al, 1973 (Brenner et al, , 1990 .
All surgical procedures were conducted by the surgical team of the Division of Laboratory Animal Medicine at the Oregon Regional Primate Research Center (ORPRC) under appropriate anaesthesia. Postsurgical medications (Flocillin; Butler Co., Columbus, OH, USA and Nubain; Dupont, Boston, MA, USA) were administered following surgery to prevent infection and discomfort. The surgical procedures resulted in minimal trauma and the animal was awake, mobile and eating within a few hours of surgery. The animals were routinely checked for infections and diseases by the veterin Studies of the intact endometrium: hormonal treatments. Spayed monkeys were treated with sequential oestradiol and progesterone in silastic implants to generate artificial menstrual cycles. Typically, to begin the cycle, an oestradiol-filled silastic implant was inserted s.c. and left in place. After 14 days, a progesterone-filled implant was inserted and then removed 14 days later, while the oestradiol implant remained in place. Menses occurred 2-3 days after the progesterone implant was withdrawn. Steroid concentrations in blood were within physiological ranges, as reported previously (Slayden et al., 1993) . The uterus was removed by hysterectomy at intervals during the cycle. We examined animals in two sets. The first data set consisted of seven animals, one animal per time point, which covered the 6 day time period subsequent to progesterone withdrawal. We referred to this period as the lutealfollicular transition because it encompassed the decline in progesterone concentration of the late luteal phase, menses and the early phases of oestrogen-driven regeneration typical of the follicular phase.
In the second set of 12 animals (one animal per time point), we evaluated days 0, 1, 2, 3, 4, 5, 6, 10, 14 and 21 of the induced cycle, and two time points (days 3 and 5) after the withdrawal of both oestradiol and progesterone (spay controls).
Northern analyses
Using a Northern blot analysis we evaluated matrilysin, stromelysins-1, -2 and -3, and the inhibitor TIMP-1. Specific probes were the 800 bp fragment of human matrilysin cDNA, the 552 bp fragment of human stromelysin-1 cDNA, the 530 bp fragment of human stromelysin-2 cDNA, the 467 bp fragment of human stromelysin-3 cDNA, and the 850 bp fragment of TIMP-1 cDNA (Newell et al, 1994) .
Procedural details
Total RNA was isolated from endometrial tissue samples by homogenization with guanidinium isothiocyanate. In general, 10 p.g total RNA were separated on a 1.2% agarose-formaldehyde gel, transferred to a nitrocellulose membrane and hybridized with random-primed cDNA probes (specific activity -1.5X 10 9 c.p.m7jig) under conditions of high stringency (hybridization, 50% formamide and 5X SSC at 42°C; wash, 0.1 X SSC at 50°C). Blots were stripped by boiling in 0.01 X Saline Sodium Citrate (SSC) and rehybridized with additional probes or with the cDNA probe for the constitutively expressed cyclophilin gene (IB 15) to control for equal loading. Filters were exposed to Kodak X-ray film or phosphor intensifying screens. A densitometric analysis was performed with an ImageQuant Molecular Dynamics, Sunnyvale, CA, USA, phosphorimager.
Ki-67 antigen immunocytochemistry
Proliferating cells were localized in frozen sections with the monoclonal antibody Ki-67 (Dako Corp., Carpinteria, CA, USA), as described previously . This antibody (Gerdes et al, 1983 (Gerdes et al, ,1984 
detects a nuclear antigen
RMSrenner et aL associated with proliferating cells, and is widely used as an index of proliferative activity (Gerdes et al., 1984; Franklin et aL, 1987) . Ki-67 antigen appears in the nucleus when cells enter the cell cycle (GO, and persists until mitosis begins. It is an essential component of the cell cycle mechanism (SchlUter et aL, 1993) . We co-localized Ki-67 antigen in the same or serial sections with various MMP to provide information on the co-expression of these molecules.
Steroid receptor immurwcytochemistry
Oestrogen and progestin receptors were detected in frozen sections with specific monoclonal antibodies and avidin-biotin (ABC) technology, as reported previously .
Matrilysin immurwcytochemistry
An affinity-purified polyclonal rabbit anti-human matrilysin antiserum (Rodgers et al., 1993) was used which recognizes matriJysin in frozen sections of monkey tissues. Recently we reported (Slayden et al., 1995) that microwave stabilization increases antigen retention and markedly enhances the morphological preservation of cryosections. Consequently, all fresh tissues were microwaveirradiated for 7 s before being imbedded in Tissue tek (Miles Inc., Elkhart, IN, USA) OCT, frozen in liquid propane and cryosectioned at 5-7 um.
In brief, our immunocytochemistry procedure was as follows. Slides bearing cryosections were microwave-irradiated again (2 s). Next they were fixed in a paraformaldehyde-picric acid fixative for 10-15 min, and then in 85% ethanol (EtOH) + 1.5% polyvinylpyrrolidone (PVP) at 4°C. Slides were then rinsed several times in 0.37% glycine in phosphate-buffered saline/PVP at 4°C to eliminate aldehyde groups. After other rinses, sections are incubated with blocking senim (20 min at 4°C) and then with primary antibody overnight in a 4 C C cold room. After rinsing and immersion in blocking serum once again, sections were incubated with secondary antibody for 30 min at room temperature (25°C). Slides were rinsed, incubated with ABC solution (Vector Laboratories, Burlingame, CA, USA) for 60 min at room temperature, treated with 3,3'-diaminobenzidine (10-15 min) and rinsed several times. Then they were treated with 0.05% OsO 4 for 1 min, rinsed, post-fixed with paraformaldehyde-picric acid, counterstained with haematoxylin, dehydrated with EtOH, cleared with xylene and mounted with permount.
Studies of endometrial autografts
The essentials of our technique for autografting both oviductal and endometrial tissue to s.c. sites have been described briefly (Brenner et al., 1987; Patton et al., 1987 Patton et al., , 1989 . Details of the technique are illustrated in Figure 1 . Spayed animals were first treated for 14 days with oestradiol-filled silastic capsules and then a progesterone-filled silastic capsule was implanted. After treatment for 8 days with oestradiol plus progesterone, an endometriectomy was performed to obtain samples of the basalis layer for grafting. The functionalis layer of the endometrium was discarded because this layer regenerated poorly. In all, 12-16 pieces -0.3 cm wideX0.5 cm longX0.2 cm thick were placed into pockets created by blunt dissection in the abdominal skin. The pockets were distributed over the abdominal surface in a matrix of four columns and four rows. The number of rows depended on the size of the animal. The progesterone capsule was left in place for 1 month, and then removed and reinserted at 2 week intervals to create a series of artificial menstrual cycles. The percentage take was usually 80%, and the established grafts menstruated in concert with the uterine menses when the progesterone capsule was withdrawn. After the endometriectomy, the eutopic endometrium regenerated in situ and underwent typical menstrual cycles. Vaginal bleeding generally resumed by the second cycle. Grafts were removed by a simple skin biopsy and were either fixed and embedded in glycolmethacrylate for a histological analysis or frozen and processed immunocytochemically for the localization of matrilysin, steroid receptors and Ki-67 antigen.
Results
Intact endometrium
Northern analysis of mRNA for MMP during induced menstrual cycles The luteal-follicular transition. We first examined MMP transcript expression in seven monkeys during the luteal-follicular transition (Figure 2) , the 6 day time period subsequent to progesterone withdrawal with the oestradiol implant remaining in place. The Northern analyses in Figure 2 suggest that an increase in the expression of stromelysin-3 was evident 1 day after progesterone withdrawal and that the other MMP were up-regulated by 2 days after progesterone withdrawal. In addition, two patterns of down-regulation (decline in expression) were evident, namely slow (Figure 2 , left panel) and fast (Figure 2, right panel) . The expression of matrilysin, stromelysin-3 and TTMP-1 mRNA showed some evidence of decline by day 6, while the expression of stromelysin-1 and -2 mRNA declined rapidly to baseline levels by day 4 and was negligible by day 6.
Continuous oestradiol with reinsertion of progesterone.
In a second set of 12 animals we evaluated a 21 day period which included days 0-14 of oestradiol treatment after progesterone withdrawal and 7 days after the reinsertion of progesterone (day 21) (Figure 3 ). In these additional animals, we confirmed that stromelysin-3 mRNA expression was increased 1 day after progesterone withdrawal, while the expression of the other MMP mRNA did not increase substantially until 2 days after progesterone withdrawal. The presence of two types of down-regulation was also confirmed. In the first type, exemplified by matrilysin, stromelysin-3 and TTMP-1, mRNA expression declined slowly, to a minimum by days 10-14. In the second type of down-regulation, indicated by stromelysins-1 and -2, the mRNA declined very rapidly, to a minimum by day 5-6 of progesterone withdrawal. The data from the first and second sets of animals, which overlapped for days 0-6, showed essentially identical patterns of mRNA regulation for each enzyme during the luteal-follicular transition.
Withdrawal of both oestradiol and progesterone.
On the far right of each panel in Figure 3 (spay controls) are data for MMP mRNA expression on days 3 and 5 of progesterone + oestradiol withdrawal. Oestradiol appeared to play a minor role in the up-regulation of the specific MMP measured in this study. More time points are needed to evaluate the effects of oestradiol on the down-regulation of these MMP mRNA. Menses appeared to occur normally in the absence of oestradiol.
lmmunocytochemistry of matrilysin and Ki-67 after progesterone withdrawal In the presence of oestradiol. Matrilysin protein was detectable by immunocytochemistry by day 3 and was sharply restricted to the glandular epithelia of the upper third of the endometrium while the mid-and basalis layers remained matrilysin- negative ( Figure 4 ). Positive staining for matrilysin was greatly reduced by day 14. Ki-67 staining ( Figure 5 ) showed that proliferative activity was greatly increased during days 4-10 and was also restricted to the glands and stroma of the upper third of the endometrium. The lower basalis regions were mitotically inactive ( Figure 5 ). After the progesterone implant was reinserted, proliferation decreased in the upper glands and then increased in the basalis, as reported previously (Koji et al, 1994) .
In the absence of oestradiol. As above, on day 5 of progesterone + oestradiol withdrawal, matrilysin protein expression was detectable by immunocytochemistry only in the glands in the upper third of the endometrium (Figure 6 ). However, Ki-67 staining was confined to the regenerating surface epithelium and was absent from the glands (Figure 6 ), confirming that oestradiol, while not essential for repair of the damaged endometrial surface after menses (Ferenczy, 1983) or for the up-regulation of matrilysin, is necessary for subsequent glandular proliferation.
Subcutaneous endometrial grafts
Figure 7 is taken from one of Markee's papers (Markee, 1940) and illustrates a typical endometrial graft in the anterior chamber of the eye of a rhesus monkey. While ocular grafts are useful for observing bleeding patterns, they are not useful for frequent serial biopsies. In rhesus monkeys, frequent serial biopsies of the intact endometrium are difficult because of the tortuosity of the cervix. As indicated in Figure 1 , multiple endometrial autografts can be placed s.c, and individual grafts can be removed at intervals by a simple skin biopsy during the course of a hormonal response. Figure 8 illustrates the abdominal skin of an animal with several well-established grafts that have been through several menstrual cycles. The raised surfaces of the grafts are caused by accumulated blood. Figure 9 is a cross-section of one of these grafts, viewed through a stereomicroscope, showing endometrial tissue surrounded by a pool of blood. The histology of a graft obtained during menstruation is shown in Figure 10 . A differentiated endometrium with upper functionalis and lower basalis regions is evident (Figure 10 , left panel). Moreover, the histological features of the menstruating tissue (Figure 10 , right panel) are similar to that of normal menstruating endometrium.
We have evaluated the regulation of steroid receptors in these grafts to determine whether they resemble normal endometrial tissue. Both oestrogen and progestin receptors are present in the grafts and they respond to hormonal changes exactly as the intact parent endometrium. In normal endometrium, progesterone treatment suppresses the progesterone receptor in the glands of the functionalis but not in the basalis region or the stroma (Brenner et al, 1988; Lessey et al, 1988; Press and Greene, 1988) . Figure 11 compares progesterone receptors by immunocytochemistry in the functionalis with the basalis in a graft taken from an animal during an artificial luteal phase. In the grafts, progesterone receptor is suppressed only in the glands of the functionalis, not the basalis, and is present throughout the stroma, as in the intact endometrium.
Localization of matrilysin by immunocytochemistry in menstruating grafts
One monkey bearing 16 established grafts was cycled artificially and then induced to menstruate by progesterone withdrawal. Two grafts were removed on each of days 0-6 of the ensuing lutealfollicular transition. The grafts menstruated as expected, beginning on day 3. Matrilysin was clearly induced in the glandular epithelium of the menstruating grafts (Figure 12 ). This observation has been confirmed in additional animals. Thus, matrilysin was up-regulated similarly in both ectopic and eutopic endometrium in association with menses. In future studies we will expand on these preliminary data and evaluate additional time points to determine the complete pattern of cyclic change in matrilysin and other MMP in grafts.
Discussion
The data collected from our rhesus monkeys have led us to a number of broad conclusions which can be summarized as follows: (i) Menses occurred after progesterone withdrawal whether or not oestradiol was present, and the MMP mRNA increased within 1 or 2 days after progesterone withdrawal, (ii) All of the MMP mRNA declined substantially during continuous oestradiol treatment, well before progesterone concentrations were elevated by the reinsertion of a progesterone implant. Two rates of decline were noted, suggesting two types of down-regulation. The first type was a slow decline to baseline by 10 days of oestradiol treatment, and was typified by matrilysin, stromelysin-3 and TTMP-1. The second type was marked by a rapid Figure 9 . Whole mount of an endometrial autotransplant. This graft was transplanted ~6 months before removal. It was removed, fixed, transected and photographed. The skin and hair are evident over the surface of the graft pocket, which is filled with blood that had accumulated from previous menses. The living graft tissue is clearly evident Original magnification -X2.5.
down-regulation, to a minimum by days 5-6 of progesterone withdrawal, and was typified by stromelysins-1 and -2. (iii) Stromelysin-3 mRNA was up-regulated within 24 h of progesterone withdrawal before menses began. Therefore this enzyme may act very early in the sequence of events which culminates in tissue destruction and sloughing of menses. Because stromelysin-3 expression persisted through a considerable part of the follicular phase, this enzyme may also play an important role in tissue remodelling. Stromelysins-1 and -2 may play roles specific to the menstrual process itself, rather than to repair or remodelling, because the mRNA of these enzymes had the shortest life-spans and were not expressed after menses ceased, (iv) Matrilysin was not detectable by immunocytochemistry until after menses began, and could be found only in the luminal and glandular epithelium of the functionalis, not in the basalis. It seems unlikely that matrilysin induces sloughing because it was expressed after sloughing began. Positive staining was often evident in the lumen, so matrilysin may function in part to 'clean up' luminal debris and in part to facilitate tissue remodelling during the early and mid-follicular phases. Similarly, to summarize our findings from studies of the s.c. grafts: (i) the regenerated grafts were often differentiated into functionalis and basalis regions analogous to those in the eutopic endometrium; (ii) menses was induced by progesterone withdrawal in the s.c. grafts, just as in the intact endometrium; and (iii) after progesterone withdrawal, matrilysin was induced in-the glandular epithelium of the grafts, just as in the intact endometrium.
These findings illustrate the role the rhesus monkey can play as a model for studies of induced menses and the associated changes in endometrial metalloproteinases. The ability to control the onset of menses and to obtain tissues at specific times before, during and after menses under defined hormonal conditions makes the macaque valuable for studies of the role of metalloproteinase gene expression in menstruation, repair and regeneration. In addition, s.c. endometrial grafts have great potential as model systems for the study of the regulation of menstrual bleeding.
Because data in monkeys reveal that after menses the mRNA of most MMP decline to near baseline levels well before progesterone concentrations rise in the luteal phase, progesterone appears to play no role in suppressing the expression of these enzymes in vivo. Consequently, it is unlikely that elevation of the MMP after progesterone withdrawal is due to relief from progesterone suppression because there is, in vivo, no progesterone suppression of such enzymes to relieve. Why then do the MMP rise after progesterone withdrawal? The answer may be that the progestationally transformed endometrium responds to progesterone withdrawal as if it were injured and produces cytokines or other biological modifiers that directly up-regulate MMP gene transcription. A proposed working model for the mechanisms underlying these events is as follows: progesterone withdrawal at the end of the menstrual cycle leads to spiral artery constriction which causes relative anoxia, induces oedema loss and results in stromal compaction. These events constitute an 'injury' to the progestationally transformed endometrium and are associated with increases in cytokines and/or other mediators which, in turn, lead to induction of the MMP. The latter participate directly in the destruction of the extracellular matrix and facilitate the weakening of vascular structural integrity associated with menses. The spatial restriction of these changes to the upper third of the endometrium strongly implicates vasoconstriction of the spiral arteries as a key player in these events, because these vessels deliver blood only to the upper endometrial regions. The two types of downregulation of the MMP mRNA, gradual versus rapid, suggest that either different MMP have different sensitivities to the same set of regulatory factors or two sets of regulatory factors are induced by progesterone withdrawal. As the endometrium heals, the 'injury' would decrease, the cytokines would decline and the MMP would decline in turn. If oestrogen is present, proliferation would begin anew in the glands of the upper third of the endometrium. This model is presented in a diagrammatic form in Figure 13 , which lists some of the cytokines that might be involved.
There are several reports that in cell or organ culture the mRNA of some MMP become elevated after progesterone withdrawal, that this increase can be suppressed by progesterone, and that these effects of progesterone are specific and receptormediated (Marbaix et al., 1992; Osteen et al.. 1994; Irwin et al, 1996) . However, cells adhering to various solid substrata or isolated in minute fragments in organ culture are metabolically, morphologically and physiologically altered from their normal state in vivo. A careful evaluation of various in-vivo studies, in which measurements of specific MMP mRNA were made directly on fresh endometrial samples obtained from women at different phases in the menstrual cycle, revealed that MMP expression increases in the late luteal, premenstrual phase (after progesterone withdrawal), persists through menses and then declines and remains low during the follicular phase, well before the rise in progesterone associated with luteal phase (e.g. see Hampton and Salamonsen, 1994; Salamonsen, 1994; Irwin et ai, 1996) . Consequently, although progesterone withdrawal is certainly associated with the up-regulation of various MMP mRNA, an elevation in progesterone concentration is not required to down-regulate them. Studies of the differentiative events that occur during progesterone-induced cellular transformations, both in vivo and in vitro, are needed to clarify the role of progesterone in endometrial MMP regulation. The commonly held view that progesterone withdrawal relieves a state of progesterone suppression of the MMP is too simplistic, because it does not explain the 'spontaneous' decline of MMP expression in the follicular phase. The rhesus monkey model can greatly facilitate the experimental analysis of such questions.
We are currently gathering additional information on several other MMP in rhesus monkeys under various hormonal conditions and will report on these elsewhere. However, our preliminary findings are interesting and should stimulate more research in this important field.
